279 related articles for article (PubMed ID: 35038609)
21. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
[TBL] [Abstract][Full Text] [Related]
22. "They make it too hard and too many hoops to jump": system and organizational barriers to drug treatment during epidemic rates of opioid overdose.
Dickson-Gomez J; Krechel S; Ohlrich J; Montaque HDG; Weeks M; Li J; Havens J; Spector A
Harm Reduct J; 2024 Feb; 21(1):52. PubMed ID: 38413972
[TBL] [Abstract][Full Text] [Related]
23. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
[TBL] [Abstract][Full Text] [Related]
24. Using machine learning to study the effect of medication adherence in Opioid Use Disorder.
Warren D; Marashi A; Siddiqui A; Eijaz AA; Pradhan P; Lim D; Call G; Dras M
PLoS One; 2022; 17(12):e0278988. PubMed ID: 36520864
[TBL] [Abstract][Full Text] [Related]
25. Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in Medicare beneficiaries.
Kuo YF; Baillargeon J; Raji MA
J Subst Abuse Treat; 2021 May; 124():108282. PubMed ID: 33771281
[TBL] [Abstract][Full Text] [Related]
26. Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.
Williams AR; Samples H; Crystal S; Olfson M
Am J Psychiatry; 2020 Feb; 177(2):117-124. PubMed ID: 31786933
[TBL] [Abstract][Full Text] [Related]
27. Suicide within 1 year of non-fatal overdose: Risk factors and risk reduction with medications for opioid use disorder.
Nowels MA; Duberstein PR; Crystal S; Treitler P; Miles J; Olfson M; Samples H
Gen Hosp Psychiatry; 2024; 86():24-32. PubMed ID: 38061284
[TBL] [Abstract][Full Text] [Related]
28. Predicting Mortality Risk After a Hospital or Emergency Department Visit for Nonfatal Opioid Overdose.
Guo J; Lo-Ciganic WH; Yang Q; Huang JL; Weiss JC; Cochran G; Malone DC; Kuza CC; Gordon AJ; Donohue JM; Gellad WF
J Gen Intern Med; 2021 Apr; 36(4):908-915. PubMed ID: 33481168
[TBL] [Abstract][Full Text] [Related]
29. Opioid use disorder and overdose among youth following an initial opioid prescription.
Hadland SE; Bagley SM; Gai MJ; Earlywine JJ; Schoenberger SF; Morgan JR; Barocas JA
Addiction; 2021 Oct; 116(10):2790-2800. PubMed ID: 33739476
[TBL] [Abstract][Full Text] [Related]
30. Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.
Shastry S; Nobel I; Allen LR; Richardson LD; Vidal K; Manini AF
Am J Emerg Med; 2022 Jan; 51():114-118. PubMed ID: 34735968
[TBL] [Abstract][Full Text] [Related]
31. Risk Factors of Prescription Opioid Overdose Among Colorado Medicaid Beneficiaries.
Dilokthornsakul P; Moore G; Campbell JD; Lodge R; Traugott C; Zerzan J; Allen R; Page RL
J Pain; 2016 Apr; 17(4):436-43. PubMed ID: 26721613
[TBL] [Abstract][Full Text] [Related]
32. Incidence rates of and risk factors for opioid overdose in new users of prescription opioids among US Medicaid enrollees: A cohort study.
Nam YH; Bilker WB; DeMayo FJ; Neuman MD; Hennessy S
Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):931-938. PubMed ID: 32648636
[TBL] [Abstract][Full Text] [Related]
33. An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.
Cochran G; Gordon AJ; Lo-Ciganic WH; Gellad WF; Frazier W; Lobo C; Chang CH; Zheng P; Donohue JM
Med Care; 2017 Mar; 55(3):291-298. PubMed ID: 27984346
[TBL] [Abstract][Full Text] [Related]
34. Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic.
Mannes ZL; Wheeler-Martin K; Terlizzi K; Hasin DS; Perry A; Pamplin JR; Crystal S; Cerdá M; Martins SS
Prev Med; 2023 Dec; 177():107789. PubMed ID: 38016582
[TBL] [Abstract][Full Text] [Related]
35. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
Larochelle MR; Bernson D; Land T; Stopka TJ; Wang N; Xuan Z; Bagley SM; Liebschutz JM; Walley AY
Ann Intern Med; 2018 Aug; 169(3):137-145. PubMed ID: 29913516
[TBL] [Abstract][Full Text] [Related]
36. Signals of increasing co-use of stimulants and opioids from online drug forum data.
Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
[TBL] [Abstract][Full Text] [Related]
37. State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees.
Lindner SR; Hart K; Manibusan B; McCarty D; McConnell KJ
JAMA Health Forum; 2023 Jun; 4(6):e231574. PubMed ID: 37351873
[TBL] [Abstract][Full Text] [Related]
38. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.
Johnson NL; Choi S; Herrera CN
J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991
[TBL] [Abstract][Full Text] [Related]
39. A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patients.
Chang HY; Krawczyk N; Schneider KE; Ferris L; Eisenberg M; Richards TM; Lyons BC; Jackson K; Weiner JP; Saloner B
Drug Alcohol Depend; 2019 Aug; 201():127-133. PubMed ID: 31207453
[TBL] [Abstract][Full Text] [Related]
40. The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates.
Tabatabai M; Cooper RL; Wilus DM; Edgerton RD; Ramesh A; MacMaster SA; Patel PN; Singh KP
J Prim Care Community Health; 2023; 14():21501319221147246. PubMed ID: 36625264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
